Home › Trial NCT01658813
5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer
- Trial IDNCT01658813
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorWestern Regional Medical Center
- Enrollment18
- Start date2012-07
- ConditionsGastrointestinal Cancer Metastatic · Renal Cell Cancer Metastatic · Non Small Cell Lung Cancer Metastatic
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.